Biogen Issues Release Highlighting Advances from Neurology Research Programs: TECFIDERA, TYSABRI Data Support Early Treatment to Improve MS Patient Outcomes, New SPINRAZA® Data Show Robust Efficacy and Safety Across a Broad Range of Individuals with SMA